Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
TransMedics
The OCS™ Liver PROTECT Trial is a two-armed, multicenter, prospective, randomized, controlled pivotal trial to evaluate the effectiveness and safety of the OCS Liver to preserve and assess donor livers intended for transplantation.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Registered male or female primary Liver transplant candidate
Age ≥18 years old
Signed: 1) written informed consent document and 2) authorization to use and disclose protected health information
You may not be if
Acute, fulminant liver failure
Prior solid organ or bone marrow transplant
Chronic use of hemodialysis or diagnosis of chronic renal failure, defined as chronic serum creatinine of \>3 mg/dl for \>2 weeks and/or requiring hemodialysis
Multi-organ transplant
Ventilator dependent
Dependent on \> 1 IV inotrope to maintain hemodynamics
